Motus GI to Release Fourth Quarter and Full Year 2021 Results and Provide a Business Update on March 29
Motus GI Holdings, Inc. (NASDAQ: MOTS) announced it will release its fourth quarter and full year financial results on March 29, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Motus GI Holdings, Inc. (NASDAQ: MOTS) announced it will release its fourth quarter and full year financial results on March 29, 2022, after market close. The company's management will host a conference call at 4:30 p.m. ET to discuss the results and recent corporate developments. The financial results will provide insights into the company's operational performance, which is critical for investors. The event will be accessible via a webcast, with a replay available on the company's website for 90 days.
Positive
- Scheduled release of fourth quarter and full year financial results on March 29, 2022.
- Management conference call offers opportunity for detailed insights into recent corporate developments.
Negative
- None.
Details
News Market Reaction – MOTS
The recorded move for MOTS in the trading session of this news was +1.14%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FORT LAUDERDALE, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its fourth quarter and full year financial results on Tuesday, March 29, 2022, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.
| Conference Call and Webcast | ||
| Date and Time: | Tuesday, March 29that 4:30 p.m. ET | |
| Domestic: | 877-407-0792 | |
| International: | 201-689-8263 | |
| Passcode: | 13727501 | |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1533147&tp_key=9ce5b7fd09 | |
A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.
About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.
Investor Contact:
Troy Williams
LifeSci Advisors
(518) 221-0106
twilliams@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.